Archive issues
Author:
Title:
Keywords:
Corrigendum
Newsletter
Enter your email:
Publications About the journal Submit manuscript CEJU Publication System Subscription Contact

2010 Vol. 63 No. 4

Review Paper2010-09-02
10.5173/ceju.2010.04.art1
Biopsy of the prostate - the urge to search for a new standard
Artur A. Antoniewicz, Łukasz Zapała, Andrzej Borówka, Theo M. de Reijke
Although the worldwide urological community generally accepts the existing protocol of TRUS-guided random prostate biopsy, there is strong evidence that sextant, extended and saturation protocols are not sufficiently accurate (ranges from 28-78%). Moreover, the number of repeated biopsies remains extremely high (33%) as a consequence of using an imperfect diagnostic tool. An overview of current literature concerning common practice in prostatic biopsies has revealed a discrepancy in indications, technique, number of cores collected, and pathological examination standards

FULL TEXT

Original Basic Research And Clinical Articles2010-09-04
10.5173/ceju.2010.04.art2
CHEK2 gene mutations, CYPB gene 355T/T polymorphism and HPV infection, approached as urinary bladder cancer predisposing factors
Monika Banaszkiewicz, Maria Constantinou, Michał Pietrusiński, Adam Jędrzejczyk, Marek Rożniecki, Piotr Marks, Bogdan Kałużewski
CHEK2 and CYP1B1 are among the genes, the mutations of which may increase the risk of cancer incidence. The multi-organ predisposition of these genes to induce neoplasm development has been reported.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FULL TEXT

Original Basic Research And Clinical Articles2010-08-18
10.5173/ceju.2010.04.art3
Isoflavones augment the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on prostate cancer cells
Ewelina Szliszka, Joanna Bronikowska, Zenon P. Czuba, Wojciech Krol
Isoflavones are the subclass of flavonoids with chemopreventive and anticancer activities. Isoflavones induce cytotoxicity and apoptosis in prostate cancer cells. TRAIL plays an important role in immune surveillance and the defense mechanism against tumor cells. However, not all tumor cells are sensitive to TRAIL. TRAIL-resistant cancer cells can be sensitized to TRAIL-induced apoptosis by flavonoids.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FULL TEXT

Case Report2010-08-17
10.5173/ceju.2010.04.art4
Primary Vaginal Stone in a Disabled Child.
Wiesław Urbanowicz, Sabina Szymik-Kantorowicz, Janusz Sulisławski, Michał Wolnicki
Authors report a case of a large primary vaginal calculus in a eleven year old girl. Vaginal stones are relatively rare. Various causes can lead to vaginal stone formation. In our case , the calculi was due to minor vaginal outlet obstruction and permanently in bed-ridden with urinary incontinence and chronic urinary infection. In our patient x-ray film using frontal and lateral views during cystography permitted to establish the right diagnosis. The treatment was surgical incision of vaginal introitus and extraction of calculi.

FULL TEXT

Case Report2010-09-14
10.5173/ceju.2010.04.art5
Rare renal tumors - Bellini duct carcinoma
Andrzej Kierstan, Marek Sosnowski, Radosław Minias, Zbigniew Jabłonowski
Bellini duct carcinoma is a rare type of renal tumor characterized by high malignancy.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FULL TEXT

Case Report2010-08-13
10.5173/ceju.2010.04.art6
Paraganglioma Displacing IVC: A Surgical Challenge
Kristell Acosta, Akin Tekin, Daniel Rosenberg, Mohan Arianayagam, Murugesan Manoharan
Paragangliomas are catecholamine-secreting tumors that originate from chromaffin cells in the sympathetic ganglia. Commonly presenting with excess cathecholamine symptoms, these tumors are usually treated with surgical excision. We present a case of an abdominal paraganglioma located between the aorta and the inferior vena cava and discuss the challenges associated with the resection of this tumor in such a complex location.

FULL TEXT

Case Report2010-08-31
10.5173/ceju.2010.04.art7
Case report: Laparoscopic radical nephrectomy in the presence of a duplicated inferior vena cava
Christopher S. Gomez, Mohan Arianayagam, Victor J. Casillas, Gaetano Ciancio
Inferior vena cava (IVC) anomalies are often asymptomatic but have considerable clinical implications during retroperitoneal surgery. While laparoscopic radical nephrectomy (LRN) has become standard of care, retroperitoneal vascular injury remains one of the more common complications. Thorough knowledge of vascular anomalies enables the surgeon to appropriately plan the operative strategy and minimize intraoperative complications. We present a case of a duplicated inferior vena cava diagnosed by computer tomography and our management of it during left sided LRN.

FULL TEXT

Case Report2015-02-25
10.5173/ceju.2010.04.art8
Primary Small Cell Carcinoma of The Bladder: A Case Report and Review of the Literature
Ahmad Omar, Nerys Williams, Nancy Chisholm, Mohammed Diab, Altaf Khattak, Leigh Forsyth
Primary small cell carcinoma is an entity or a disease. Despite its agressive clinical course, there is no consensus on an optimal treatment approach. We hereby present a localized terminal stage small cell bladder carcinoma case along with the related literature. A man at 81 has admitted to the clinic with massive hematuria complain. In radiological examination, a tumoral mass at nearly cm diameter was observed in bladder. Tissue biopsy samples were taken via transurethral resection method. In histopathological examination, primary small cell carcinoma cells were found.

FULL TEXT

Case Report2010-08-23
10.5173/ceju.2010.04.art9
SQUAMOUS CELL CARCINOMA CAUSED BY NEGLECTED GIANT BLADDER DIVERTICULUM STONE: CASE REPORT
Hasan Kocoglu, Cabir Alan
The incidence of bladder diverticula is approximately 1.7% in children and 6% in adults. Bladder tumors arising inside of a diverticula are uncommon, with a reported incidence ranging from 0.8% to 10%. In literature a large number of cases dealing with squamos cell carcinoma caused by bladder diverticula. Until now, a case report depicting the coexistence of these pathologies (SCC, diverticula and diverticula stone) simultaneously in one case has not been reported yet. In our case neglected bladder diverticulum stones may cause SCC

FULL TEXT

Case Report2010-09-12
10.5173/ceju.2010.04.art10
HUMAN OS PENIS : A CASE REPORT
Ahmet Resit Ersay, Cabir Alan, Hasan Kocoglu
This report presents a case of a 5-year-old male suffering from a rod-like mass at the base of penis. He was aware of its existence since pubertal ages. Physical examination revealed a bone hard, mobile, stick- like structure behind the corpus spongiosum, at median plane. A calcified periurethral rod-like 5cm. Mass at the ventral aspect of intercorporeal septum of penis was noted on CT scan. The patient who had no symptoms associated with erectile dysfunction refused further diagnostic tests and intervention.

FULL TEXT

Dear Colleagues!

Please forgive me for this somewhat reflective mood, but it is caused by the up- coming end of the 2015-2018 term of the PUA Executive Board. As you probably know, the Editor-in-Chief of the Central European Journal of Urology is appointed by the PUA Executive Board, which is why this introductory article is somewhat of a summary.

So then, for this reason, I would like to share some information about the development of the journal. The journal is developing very well. When analyzing the names of the authors, we can see that we are recognizable not only in Europe but also around the world. Urologists from large academic centers publish their articles in our journal. We operate on an "open access" basis and therefore do not charge any fees. This is undoubtedly an asset. An expression of this is the growing number of our citations. The CiteScore coefficient for the Central European Journal of Urology is currently 1.11, while last year it was 0.70. The systematic increase in citations year by year sets the stage to move us from Emerging Cites Sources and promote us to the Science Citation Index Expanded, managed by Clarivate Analytics, formerly Thomson Reuters, which is associated with the granting of the socalled "Impact Factor". I first submitted our journal in 2015 and the assessment, at that time made by Thomson Reuters, was that we should remain in the "waiting room", and therefore we were included in Emerging Sources Citation Index. I submitted my second request for re-assessment at the end of 2017 and I am currently awaiting an answer. I hope to get a positive decision.

Building a urological journal in Europe is not a simple task. We already have journals of recognized position and reputation, such as European Urology, European Urology Focus, as well as World Journal of Urology, Urologia Internationalis, Scandinavian Journal of Urology and International Urology and Nephrology. There are also newly created journals such as European Urology Oncology which has very strong support from the European Association of Urology. We must show that we are needed in Central Europe! We do not have anything to prove!

The standing of a scientific journal depends firstly on the quality of the materials submitted, that is from the authors' workshops. However, this is only one side of the coin!

The team of people who verifies submitted scientific materials is also very crucial. This is probably the most important thing that I would like to convey. Usually, I do not officially direct words of thanks to my colleagues, because I think that they consciously chose the tasks they carry out in their lives. At this point, however, at the end of the 2015-2018 term of the PUA Executive Board, I would like to thank Dr. Bartosz Dybowski, my assistant Editor-in-Chief, for the enormous amount of work and time devoted to the extremely professional preparation of each issue. His ex- pert knowledge and availability could be the envy of many a manager. Without the hard work of Dr. Dybowski, this journal would not look like it does today, and the choice of his person for this position was certainly the right one.

I would also like to personally thank our section editors for their hard work and input. Przemysław Adamczyk, Ewa Bres-Niewada, Stefan Buntrock, Abdullah Erdem Canda, Michał Ciszek, Olga Dolejšová, Simona Di Francesco, Jan Hrbáček, Kajetan Juszczak, George Kasyan, Daimantas Milonas, Maciej Salagierski and Przemysław Waliszewski have always stood up to the task. Dear Colleagues, I know how much you have done for the journal, I appreciate it, and I will always remember your commitment.

Nothing could be done without the huge backing of internationally recognized professionals, without which the magazine would not be in the right form and would not grow. The Consulting Editors and the Editorial Board are these advisory bodies that I would like to thank for their knowledgeable comments and support in making difficult decisions.

Also, I would like to recognize the Reviewers, who often work "behind the scenes" but are nonetheless extremely helpful. Their complete independence allows them to give us their wise and unbiased opinions. Thank you for your support during the entire 2015-2018 term.

In conclusion, it is my sincere hope that the journal will continue to develop even better and even more vigorously in the coming years.


Tomasz Drewa
Editor-in-Chief

Menu

About the journal

Subscription

Contact

Publications

Ahead of print

Current issue

Users

Submit manuscript

Instructions for authors

CEJU Publication System

© Copyright by Polish Urological Association

Logo CEJU

Logo CEJU
Corrigendum
The Editorial Office would like to inform all interested parties that in Central European Journal of Urology an article entitled "Efficacy of holmium laser urethrotomy and intralesional injection of Santosh PGI tetra-inject (Triamcinolone, Mitomycin C, Hyaluronidase and N-acetyl cysteine) on the outcome of urethral strictures" [Kumar S, Kishore L, Sharma AP, Garg N, Singh SK. Cent European J Urol. 2015; 68: 462-465] was published which is very similar to the article entitled "Efficacy of Optical Internal Urethrotomy and Intralesional Injection of Vatsala-Santosh PGI Tri-Inject (Triamcinolone, Mitomycin C, and Hyaluronidase) in the Treatment of Anterior Urethral Stricture" published in Advances in Urology [Kumar S, Garg N, Singh SK, Mandal AK. Adv Urol. 2014; 2014: 192710. doi: 10.1155/2014/192710. Epub 2014 Oct 1].

The authors of these articles did not inform the CEJU Editorial Office about the prior publication of an article with a similar subject matter nor did they refer to it in their References section.

The Editorial Office regrets the existing situation.